geriatric pharmacokinetics and dosing optimization of therapeutic antibodies — Alzheimer's disease — Research Gap | InTree.AI

Research Gap

geriatric pharmacokinetics and dosing optimization of therapeutic antibodies — Alzheimer's disease

How do age-related changes in pharmacokinetics affect optimal dosing of anti-amyloid monoclonals?

sparse evidenceInterestingness: 56.0

Discovered by InTree.AI — analyzing 250M+ scientific papers

Under Maintenance

Under maintenance — back shortly

Maintenance in progress

geriatric pharmacokinetics and dosing optimization of therapeutic antibodies — Alzheimer's disease — Research Gap | InTree.AI | InTree